R. Oratz

D. Roses, R. Shapiro, J. Bystryn, 2001, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.

A. Zeleniuch‐Jacquotte, H. Hochster, A. Chachoua, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Modulation of monocyte functions by muramyl tripeptide phosphatidylethanolamine in a phase II study in patients with metastatic melanoma.

D. Peace, H. Hochster, A. Chachoua, 1992, Journal of the National Cancer Institute.

Phase Ib Trial of Granulocyte‐Macrophage Colony‐Stimulating Factor Combined with Murine Monoclonal Antibody R24 in Patients with Metastatic Melanoma

J. Vilček, D. Peace, A. Chachoua, 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Antimelanoma monoclonal antibody-ricin A chain immunoconjugate (XMMME-001-RTA) plus cyclophosphamide in the treatment of metastatic malignant melanoma: results of a phase II trial.

H. Hochster, L. Spitler, R. Mischak, 1990, Journal of biological response modifiers.

Biologic Activity of Interleukin 1 (IL‐1) Alpha in Patients with Refractory Malignancies

D. Peace, M. Rosenthal, A. Chachoua, 1998, Journal of immunotherapy.

Survival with regional and distant metastases from cutaneous malignant melanoma.

N. Dubin, D. Roses, N. Karp, 1991, Surgery, gynecology & obstetrics.

Diabetes and differences in detection of incident invasive breast cancer

D. Boudreau, Stephen Richardson, H. Gold, 2019, Cancer Causes & Control.

Fusion of Functional Spect Images with Structural CT/MRI Images

Gerald Q. Maguire, A. Megibow, M. Noz, 1991 .

Phase II clinical trial of recombinant alpha 2b interferon and 13 cis retinoic acid in patients with metastatic melanoma.

M. Rosenthal, R. Oratz, 1998, American journal of clinical oncology.

Superior Vena Cava Syndrome and Breast Cancer: A Case Series Highlighting a Rare Complication

F. Muggia, R. Oratz, N. Gerber, 2022, Current Problems in Cancer: Case Reports.

Acquired Immune Deficiency Syndrome

F. Muggia, A. Chachoua, M. Green, 1987 .

Immunogenicity of a polyvalent melanoma antigen vaccine in humans

D. Roses, J. Bystryn, M. Harris, 1988, Cancer.

Lack of effect of cyclophosphamide on the immunogenicity of a melanoma antigen vaccine.

D. Roses, H. Hochster, J. Bystryn, 1991, Cancer research.

Double-blind trial of a polyvalent, shed-antigen, melanoma vaccine.

D. Roses, A. Zeleniuch‐Jacquotte, R. Shapiro, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Double-Blind Trial of a Polyvalent , Shed-Antigen , Melanoma Vaccine 1

D. Roses, A. Zeleniuch‐Jacquotte, R. Shapiro, 2001 .

Induction of tumor-infiltrating lymphocytes in human malignant melanoma metastases by immunization to melanoma antigen vaccine.

D. Roses, C. Cockerell, J. Bystryn, 1989, Journal of biological response modifiers.

Identification of melanoma antigens that are immunogenic in humans and expressed in vivo.

R. Shapiro, J. Bystryn, R. Oratz, 1998, Journal of the National Cancer Institute.

Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment.

W. Symmans, S. Demaria, H. Yee, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cancer Risk Assessment Using Genetic Panel Testing: Considerations for Clinical Application

H. Ostrer, F. Schnabel, S. Hiraki, 2014, Journal of Genetic Counseling.

Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation

H. Ostrer, E. John, I. Andrulis, 2013, Human Genetics.

Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy.

W. Symmans, S. Demaria, W. Symmans, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer.

C. Vogel, S. Chia, F. Muggia, 2007, Clinical breast cancer.

Cost-effectiveness of 21-gene assay in node-positive, early-stage breast cancer.

M. Broder, E. Chang, T. Bentley, 2011, The American journal of managed care.

Elective radiation therapy for high-risk malignant melanomas.

J. Cooper, D. Roses, R. Shapiro, 2001, Cancer journal.

Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer.

M. Broder, R. Bugarini, C. Chao, 2011, Journal of oncology practice.

Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer.

A. Cohn, R. Oratz, S. Sedlacek, 2007, Journal of oncology practice.

Monocyte Activation Following Systemic Administration of Granulocyte‐Macrophage Colony‐Stimulating Factor

J. Vilček, D. Peace, A. Chachoua, 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 Pandemic

J. Kucharczyk, S. Adams, M. Kwa, 2022, The oncologist.

Intratumoral cisplatin/adrenaline injectable gel for the treatment of patients with cutaneous and soft tissue metastases of malignant melanoma

A. Hauschild, D. Schadendorf, D. Castro, 2003, Melanoma research.

Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study.

A. Zeleniuch‐Jacquotte, H. Hochster, A. Chachoua, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II Trial of Dacarbazine and Thalidomide for the Treatment of Metastatic Melanoma

P. Ott, A. Pavlick, F. Muggia, 2009, Chemotherapy.

Editorial : Gene Expression Profile Assays As an Aid in Treatment Decision Making in Early-Stage Breast Cancer

A. Cohn, R. Oratz, S. Sedlacek, 2007 .

Risk for SARS-CoV-2 infection in patients with breast cancer treated with chemotherapy, biologic therapy or active surveillance: Patient outcomes from multicenter institution in New York.

J. Kucharczyk, S. Adams, M. Kwa, 2021 .

Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancer

L. Braunstein, D. Barbee, F. Schnabel, 2023, Breast Cancer Research and Treatment.

Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer

D. Boudreau, M. Hammer, Stephen Richardson, 2019, American journal of clinical oncology.

INTRAVITREAL BEVACIZUMAB IN THE MANAGEMENT OF BREAST CANCER IRIS METASTASIS

P. Finger, R. Oratz, J. Silverman, 2017, Retinal cases & brief reports.